EDAP TMS SA (Nasdaq:EDAP) announced today that the FDA granted 510(k) clearance for new workflows for its ultrasound ...

Clearance for Latest Evolution of Focal One Robotic HIFU AUSTIN, Texas, November 20, 2025 - EDAP TMS SA (Nasdaq: EDAP), ...

EDAP TMS SA announced the successful treatment of the first patient in its phase I/II PULS Trial, which is investigating the use of High Intensity Focused Ultrasound (HIFU) technology for pancreatic ...

EDAP TMS ( ($EDAP) ) has shared an update. On November 20, 2025, EDAP TMS announced that it received FDA 510(k) clearance for enhancements to its ...

LYON, France, October 1, 2024 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, today announced that the first patients have been treated in a Phase I/II study evaluating the ...

AUSTIN, Texas, January 8, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial ...

Focal One's precision means qualifying prostate cancer patients can forego prostate removal surgery and avoid life-altering side effects including incontinence and impotence LYON, France - April 1, ...

EDAP TMS S.A. (($EDAP)) has held its Q3 earnings call. Read on for the main highlights of the call. EDAP TMS S.A. recently held its earnings call, ...

John Wayne Cancer Institute (JWCI) at Providence Saint John’s Health Center is once again breaking new ground to benefit cancer patients. It has become the first medical center in the country to ...

Medical professionals have described the introduction of High-Intensity Focused Ultrasound (HIFU) technology for treating fibroids in Nigeria as a significant feat. The deployment of the technology by ...